Absci (ABSI) Current Leases (2020 - 2026)
Absci's (ABSI) quarterly Current Leases came in at $1.9 million in Q1 2026, up 5703.12% year-on-year from $32000.0 in Q1 2025, and up 2.88% quarter-over-quarter from $1.8 million in Q4 2025.
Absci (ABSI) Current Leases (2020 - 2026) Analysis & Trends
Absci has disclosed Current Leases across 7 years of filings, most recently posting $1.9 million for Q1 2026.
- Current Leases for Q1 2026 came in at $1.9 million, up 5703.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (up 5703.12% YoY), and the FY2025 annual result was $1.8 million, up 12.25% from the prior year.
- Current Leases came in at $1.9 million for Q1 2026 at Absci, up from $1.8 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $2.8 million in Q1 2022 to a low of $32000.0 in Q1 2025.
- The 5-year median for Current Leases is $1.6 million (2022), against an average of $1.5 million.
- Across the five-year window, Current Leases slumped 97.98% in 2025 and jumped 5703.12% in 2026, its largest moves.
- Absci's Current Leases stood at $1.7 million in 2022, then tumbled by 62.07% to $641000.0 in 2023, then surged by 150.86% to $1.6 million in 2024, then advanced by 12.25% to $1.8 million in 2025, then climbed by 2.88% to $1.9 million in 2026.
- The last three Current Leases figures came in at $1.9 million (Q1 2026), $1.8 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.86 Mn |
| Dec 31, 2025 | 1.81 Mn |
| Sep 30, 2025 | 1.75 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 32,000.00 |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 140,000.00 |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 641,000.00 |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 1.54 Mn |
| Mar 31, 2023 | 2.03 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | 1.64 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 2.77 Mn |
| Dec 31, 2021 | 2.79 Mn |
| Sep 30, 2021 | 2.77 Mn |
| Jun 30, 2021 | 1.42 Mn |